The hidden gem at 360biolabs is the extensive virological expertise. Decades of Executive and Lead Scientist experience in the antiviral drug discovery and development space has ensured the team can support any virological end point you may need. From classical virology including culture and PRNT to molecular quantitative and qualitative PCR, 360biolabs can offer the full suite of virological endpoints for your clinical endpoints. In the molecular age, it can be challenging to find a team with cell culture-based virology expertise and when we combine our virology, immunology and molecular biology teams, 360biolabs can support any end point required for vaccine or antiviral discovery and development. Physical containment 2 and 3 laboratories and training and access to physical containment 4 laboratories allow us to support any vaccine or antiviral agent in development.